Oppenheimer:" Biotech Top Picks for 2026: $ALMS, $AXSM, $CAPR, $CNTA, $GOSS, $MDGL, $PVLA, $TYRA, $WVE...2H25 rebound in M&A extending into 2026 as big pharma races to replace >$170B patent cliff by 2032...."

@tomsilver39 I wrote about this to happen eventually for the first time in March 2023, almost three years ago. however, I must admit that I am a bit surprised how big these deals are. Big dollars for relatively small / pre-sales entities.